Sources | Names Used |
---|---|
GDSC1000 | QL-VIII-58 |
PharmacoGx | QL-VIII-58 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TINAG | GDSC1000 | pan-cancer | AAC | -0.1 | 0.02 |
mRNA | SSFA2 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
mRNA | ZCCHC7 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.03 |
mRNA | PHLDA3 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.03 |
mRNA | RAB28 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
mRNA | SLC20A2 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
mRNA | SGTB | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
mRNA | CRP | GDSC1000 | pan-cancer | AAC | -0.098 | 0.03 |
mRNA | CR2 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.03 |
mRNA | CHP1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |